Clinical Genomics Uppsala announces a call for strategic collaborative projects
The mission of Clinical Genomics Uppsala is to catalyze the transition of genomics-based methods from research to healthcare. We have a specific focus on development of new clinical applications based on ultrasensitive variant detection and liquid biopsies, including digital PCR, ctDNA analysis and NGS with UMIs, and long-read sequencing. To accelerate technology development within these areas, we now invite researchers across Sweden to apply for strategic collaborative projects.
Selected project will benefit from cost-effective access to our comprehensive end-to-end services, that can include everything from support with project design, nucleic acid extraction, molecular and bioinformatic analysis to clinical interpretation of genetic variants.
What type of projects are we looking for?
- Samples must be ready to be analyzed during 2025. This means that ethical and biobank approvals must already be in place.
- Projects can include development of laboratory and/or bioinformatic workflows.
Application
Apply for a strategic collaborative project here
Feel free to contact us at clinicalgenomicsuppsala@scilifelab.se if you want to discuss your project prior to submitting the application.
Evaluation
Project proposals will be evaluated by the CGU management group based on the following criteria:
- Clinical relevance of the project
- Scientific quality of the project
- Feasibility to perform the project during 2025
- Strategic importance and alignment between the project and CGU’s goals
Timeline
- April 29, 2025: Deadline for application.
- May 28, 2025: Decision on selected projects communicated to applicants.
- September 1, 2025: Deadline for delivery of samples for selected projects.
Learn more about our services at the CGU website
Please send any questions about the call to clinicalgenomicsuppsala@scilifelab.se
